Exclusion based on Minimum Non Zero Concentrations [Design Issues]

posted by hiren379 – India, 2012-12-11 06:31 (4942 d 07:06 ago) – Posting: # 9706
Views: 4,745

Hello All,
We are planning pivotal biostudy for one of the highly variable molecule (DR Formulation). We have conducted pilot Ref-replicated biostudy, but were suprised with few observations...

1) Inspite of >35 samples we got last point Cmax in 4 subjects in Reference arm:confused
2) After 3-4 zero concentrations in some subjects, we are getting Cmax immediately in next time point. This is similar to first point Cmax.
3) We got just 2 non zero concentrations in 4 subjects and 3 non zero concentrations in 3 subjects in Reference arm. Concentrations are rising and falling very sharply.
::confused:
We are planning to keep an exclusion criteria in our Pivotal study like.
Subjects having minimum of 4 non zero concentrations will be included in the study if first and last points are not Cmax.

Please guide on regulatory acceptability (particularly for USFDA) of such criterion.

If this can be handeled with some other criteria, please suggest...

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
215 visitors (0 registered, 215 guests [including 117 identified bots]).
Forum time: 14:37 CEST (Europe/Vienna)

Competence, like truth, beauty and contact lenses,
is in the eye of the beholder.    Laurence J. Peter

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5